Donna Tan

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim et al. · The Lancet Diabetes & Endocrinology · 2020 · 93 citations · Full text

Medicine, Cardiology, Pharmacology +12

Toxoplasma gondii infection and testosterone congruently increase tolerance of male rats for risk of reward forfeiture

Donna Tan, Ajai Vyas · Hormones and Behavior · 2016 · 32 citations · Full text

Medicine, Behavioral Sciences, Endocrinology +10

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim et al. · Cardiovascular Diabetology · 2021 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Infection of male rats with<i>Toxoplasma gondii</i>results in enhanced delay aversion and neural changes in the nucleus accumbens core

Donna Tan, Linda Jing Ting Soh, Lee Wei Lim et al. · Proceedings of the Royal Society B Biological Sciences · 2015 · 27 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17